PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Neopac takes a majority stake in 3D Technopack

Hoffmann Neopac AG, a leading supplier of tube packaging to the worldwide pharmaceutical and cosmetics industries based in Switzerland, has taken a majority stake in 3D Technopack Pvt. Ltd. based in Mumbai, India. This investment strengthens the company’s international market presence and expands its expertise in tube manufacturing.
 
3D Technopack has been on the market since 2003 and is the third-largest tube manufacturer in India. The company is regarded as a quality and innovation leader in its own country, is ISO 9001 and BRC certified, has 220 employees and produces 120 million tubes per year. 3D is a supplier of tubes to major brands in India as well as to mid sized companies in Europe.
Funding provided by Neopac will be used to expand capacity in 3D’s core extruded tube business as well as the launch of a new tube generation pioneered by 3D Technopack which allows unlimited decoration.
 
Hoffmann Neopac is mainly active in Europe and North America. With a majority stake in 3D Technopack, the company is ensuring its foothold in the fast-growing Asian tube market. By expanding its geographic presence, Hoffmann Neopac is equally strengthening its position as a partner for globally active cosmetics and pharmaceutical corporations.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026